Long-term trends in the burden of leukemia subtypes in China from 1990 to 2021: a Joinpoint regression and age-period-cohort analysis based on GBD 2021

医学 髓系白血病 白血病 入射(几何) 人口学 流行病学 队列 疾病负担 中国 疾病 慢性淋巴细胞白血病 代群效应 队列研究 免疫学 肿瘤科 环境卫生 人口 年龄组 急性淋巴细胞白血病 内科学 髓样
作者
Yudi Shangguan,Xinyue Gou,Yue Luo,Zhuo Chen
出处
期刊:Frontiers in Medicine [Frontiers Media]
卷期号:13: 1826237-1826237
标识
DOI:10.3389/fmed.2026.1826237
摘要

Background: Leukemia subtypes have distinct epidemiological profiles, but comprehensive comparisons of their long-term burden in China remain limited. This study assessed trends in four major leukemia subtypes from 1990 to 2021 and projected incidence rates over the subsequent 25 years. Methods: We used data from the Global Burden of Disease (GBD) 2021 database to analyze the burden of acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL) in China from 1990 to 2021, stratified by age and sex. Joinpoint regression, age-period-cohort (APC) modeling, and Bayesian APC modeling were applied to assess temporal trends, estimate age, period, and cohort effects, and project future incidence. We also summarized disability-adjusted life years (DALYs) attributable to GBD-estimated risk factors for leukemia and its subtypes. Results: In 2021, there were an estimated 105,670 new leukemia cases in China. Among the four subtypes, ALL had the highest overall burden, whereas CML had the lowest burden and showed the greatest declines in incidence, deaths, and DALYs. Joinpoint analysis revealed that the age-standardized incidence rates (ASIRs) declined for AML and CML but increased for ALL and CLL. APC analysis indicated that age was the primary determinant of incidence, with distinct age distributions and cohort patterns across subtypes. BAPC projections indicated that incidence rates would remain stable for AML and CML, gradually decline for ALL, and continue to rise for CLL through 2046. Smoking and high body-mass index were the main contributors to attributable DALYs. Conclusion: Leukemia subtypes in China show distinct long-term incidence trends. The decreasing burden of AML and CML may be associated with improvements in access to diagnosis and treatment, whereas rising ALL and CLL incidence pose new public health challenges, especially among children and the elderly. Tailored, subtype- and age-specific strategies are essential for effective leukemia control and resource planning.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被懒狗采纳,获得10
刚刚
Spteer完成签到,获得积分10
刚刚
1秒前
2秒前
追寻清完成签到,获得积分0
3秒前
飞天三叉戟完成签到,获得积分10
3秒前
秋分前完成签到,获得积分10
3秒前
一见发布了新的文献求助10
3秒前
852的应助被落落采纳,获得10
4秒前
4秒前
guo完成签到,获得积分10
4秒前
思源的应助被田浩阳采纳,获得10
5秒前
5秒前
5秒前
宇宙不小欣完成签到 ,获得积分10
5秒前
5秒前
6秒前
wxywdd完成签到,获得积分10
7秒前
8秒前
9秒前
syvshc的应助被白塔采纳,获得20
9秒前
dxmin完成签到,获得积分10
10秒前
传奇3的应助被老张采纳,获得10
11秒前
111完成签到,获得积分10
11秒前
11秒前
yang发布了新的文献求助10
12秒前
宜醉宜游宜睡完成签到,获得积分0
12秒前
QULr完成签到,获得积分10
12秒前
洁净山柏发布了新的文献求助10
12秒前
13秒前
fishuae发布了新的文献求助10
13秒前
小人物小梦想完成签到,获得积分10
13秒前
13秒前
14秒前
明明完成签到,获得积分10
14秒前
14秒前
小人物丿发布了新的文献求助20
15秒前
赵雅芝发布了新的文献求助30
15秒前
bill完成签到,获得积分10
15秒前
幸福MENG_发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175429
求助须知:如何正确求助?哪些是违规求助? 9567162
关于积分的说明 21790896
捐赠科研通 7769976
什么是DOI,文献DOI怎么找? 3431849
关于科研通互助平台的介绍 2556237
邀请新用户注册赠送积分活动 2477281